Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The majority of genetic risk variants for type 2 diabetes (T2D) affect insulin secretion, but the mechanisms through which they influence pancreatic islet function remain largely unknown. We functionally characterized human islets to determine secretory, biophysical, and ultrastructural features in relation to genetic risk profiles in diabetic and nondiabetic donors. Islets from donors with T2D exhibited impaired insulin secretion, which was more pronounced in lean than obese diabetic donors. We assessed the impact of 14 disease susceptibility variants on measures of glucose sensing, exocytosis, and structure. Variants near TCF7L2 and ADRA2A were associated with reduced glucose-induced insulin secretion, whereas susceptibility variants near ADRA2A, KCNJ11, KCNQ1, and TCF7L2 were associated with reduced depolarization-evoked insulin exocytosis. KCNQ1, ADRA2A, KCNJ11, HHEX/IDE, and SLC2A2 variants affected granule docking. We combined our results to create a novel genetic risk score for β-cell dysfunction that includes aberrant granule docking, decreased Ca2+ sensitivity of exocytosis, and reduced insulin release. Individuals with a high risk score displayed an impaired response to intravenous glucose and deteriorating insulin secretion over time. Our results underscore the importance of defects in β-cell exocytosis in T2D and demonstrate the potential of cellular phenotypic characterization in the elucidation of complex genetic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“At the time of writing, over 60 genetic loci have been convincingly associated with T2D”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [9]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the great majority in some way involved in β-cell biology, underscoring the importance of β-cell dysfunction in T2D pathogenesis ( 8 , 9 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This argues that the small (25%) reduction in β-cell/islet insulin content associated with T2DM (576) should not be of major pathophysiological importance and that other functional defects (for example, impaired initiation of electrical activity) are more significant drivers of disease.”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [576]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets
Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., & Maedler, K. (2008) · Diabetes · doi:10.2337/db07-0847 · Cited by 265
Retractedβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993 · cited 1×
“Rs13266634 (SLC30A8) is the second most strongly associated T2D variant identified to date (1), but previous population studies have shown inconsistent effects of the variant on insulin secretion (31,32).”
BackgroundGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Self-citationThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“Human islets from donors with the TCF7L2 rs7903146 risk genotype, the genetic variant with the largest effect on T2D susceptibility known to date (20,21), displayed significantly reduced insulin secretion (P = 0.”
BackgroundWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Self-citationTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Self-citationGloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137 · cited 1×
“Activating mutations in KCNJ11 are a cause of neonatal diabetes (23), and the nonsynonymous rs5219 risk allele of the channel (E23K) combined with the S1369A risk allele of the neighboring ABCC8 (encoding the sulfonylurea receptor 1) exhibits decreased ATP inhibition (24).”
BackgroundSelf-citationInsulin granule dynamics in pancreatic beta cells
Rorsman, P., & Renstr�m, E. (2003) · Diabetologia · doi:10.1007/s00125-003-1153-1 · Cited by 844 · cited 2×
“A current hypothesis postulates that first-phase insulin secretion reflects the release of granules docked beneath the plasma membrane, whereas second phase requires physical recruitment of granules from the cell interior and/or chemical modification (priming) of granules already in place beneath the membrane (16), al…”
BackgroundSelf-citation
Cited by
Items 101–200 of 237
Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic β-cells
Rajasekaran, S. S., Kim, J. J., Gaboardi, G.-C., Gromada, J., Shears, S. B., dos Santos, K. T., Nolasco, E. L., Ferreira, S. D. S., Illies, C., Köhler, M. G., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.001 · Cited by 28
MAFA and MAFB regulate exocytosis‐related genes in human β‐cells
Cataldo, L. R., Singh, T., Achanta, K., Bsharat, S., Prasad, R. B., Luan, C., Renström, E., Eliasson, L., & Artner, I. (2022) · Acta Physiologica · doi:10.1111/apha.13761 · Cited by 28
Self-citationTCF7L2 and Diabetes: A Tale of Two Tissues, and of Two Species
McCarthy, M. I., Rorsman, P., & Gloyn, A. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.011 · Cited by 27
Self-citationKCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors
Gotthardová, I., Javorský, M., Klimčáková, L., Kvapil, M., Schroner, Z., Kozárová, M., Malachovská, Z., Ürgeová, A., Židzik, J., & Tkáč, I. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.018 · Cited by 27
Chen, L., Sun, Q., Liu, S., Hu, H., Lv, J., Ji, W., Wang, M., Chen, M., & Zhou, J. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4006 · Cited by 31
Shomorony, A., Pfeifer, C. R., Aronova, M. A., Zhang, G., Cai, T., Xu, H., Notkins, A. L., & Leapman, R. D. (2015) · Journal of Microscopy · doi:10.1111/jmi.12276 · Cited by 25
“For example, type two diabetes is characterized by defective insulin secretion, as well as atypical glucagon secretion, associated with changes in islet function and islet mass (Rosengren et al., 2012; Brereton et al., 2014).”
BackgroundModulation of insulin secretion by RBFOX2-mediated alternative splicing
Moss, N. D., Wells, K. L., Theis, A., Kim, Y.-K., Spigelman, A. F., Liu, X., MacDonald, P. E., & Sussel, L. (2023) · Nature Communications · doi:10.1038/s41467-023-43605-4 · Cited by 29
“The decreased insulin secretion can be attributed to disruption in insulin granule distribution, docking, and exocytosis 5,9,10 .”
Riobello, C., Gómez, J., Gil‐Peña, H., Tranche, S., Reguero, J. R., de la Hera, J. M., Delgado, E., Calvo, D., Morís, C., Santos, F., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.007 · Cited by 26
“…secretion, suggesting that the risk alleles of this, and other KCNQ1 intronic SNPs, may have a gain-of-function effect resulting in increased susceptibility to T2DM through increased protein expression and decreased insulin exocytosis and secretion (Rosengren et al., 2012; Tan et al., 2009).”
BackgroundFu, J., Githaka, J. M., Dai, X.-Q., Plummer, G., Suzuki, K., Spigelman, A. F., Bautista, A., Kim, R., Greitzer-Antes, D., Fox, J. E. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127896 · Cited by 30
Metabolomics Analysis of Nutrient Metabolism in β-Cells
Spégel, P., & Mulder, H. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.07.020 · Cited by 26
Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans
LAURENTI, M. C., Man, C. D., Varghese, R. T., Andrews, J. C., Rizza, R. A., Matveyenko, A. V., Nicolao, G. D., Cobelli, C., & Vella, A. V. (2020) · JCI Insight · doi:10.1172/jci.insight.136136 · Cited by 23
Fusion pore in exocytosis: More than an exit gate? A β-cell perspective
Hastoy, B., Clark, A., Rorsman, P., & Lang, J. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.10.005 · Cited by 29
Self-citationHorikoshi, M., Pasquali, L., Wiltshire, S., Huyghe, J. R., Mahajan, A., Asimit, J. L., Ferreira, T. C., Locke, A. E., Robertson, N. R., Wang, X., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw048 · Cited by 24
“1 in β-cells has been previously demonstrated to increase exocytosis and secretion of insulin (37), and patients with loss-”
BackgroundSelf-citationRattanatham, R., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Sawanyawisuth, K., Intharaphet, P., Senthong, V., & Settasatian, C. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0101 · Cited by 24
“1) could decrease insulin exocytosis and reduce insulin secretion [46].”
BackgroundGerencser, A. A. (2015) · Endocrinology · doi:10.1210/en.2015-1552 · Cited by 24
Inhibition of secreted frizzled-related protein 5 improves glucose metabolism
Rulifson, I. C., Majeti, J. Z., Xiong, Y., Hamburger, A., Lee, K. J., Li, M., Lu, M. P., Gardner, J., Gong, Y., Wu, H. Y., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2014 · Cited by 23
“Although expressed in many tissues, the variant in TCF7L2 associates with impaired pancreatic -cell insulin secretion and -cell survival (8, 9, 17, 18, 20, 21, 33, 37, 40, 41, 47).”
BackgroundZhang, W., Wang, H., Guan, X., Niu, Q., & Li, W. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.05.004 · Cited by 22
“We also found that compared with genotypes TT and CT, genotype CC was associated with a tendency of increasing incidence of hypertension and macrovascular complications in patients with T2DM.”
ResultZhang, J., Juhl, C. R., Hyltén-Cavallius, L., Salling-Olsen, M., Linneberg, A. R., Holst, J. J., Hansen, T. F., Kanters, J. K., & Torekov, S. S. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0513-x · Cited by 21
Lubberding, A. F., Juhl, C. R., Skovhøj, E. Z., Kanters, J. K., Mandrup-Poulsen, T. R., & Torekov, S. S. (2022) · Acta Physiologica · doi:10.1111/apha.13781 · Cited by 22
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
Daniele, G., Gaggini, M., Comassi, M., Bianchi, C., Basta, G., Dardano, A., Miccoli, R., Mari, A., Gastaldelli, A., & Prato, S. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1172 · Cited by 21
The Kv7 Channel and Cardiovascular Risk Factors
Fosmo, A. L., & Skraastad, Ø. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00075 · Cited by 24
“1, as well as KCNQ1 knockdown with siRNA, increased exocytosis and insulin secretion in pancreatic β-cells (67).”
BackgroundCholesterol Redistribution in Pancreatic β-Cells: A Flexible Path to Regulate Insulin Secretion
Galli, A., Arunagiri, A., Dule, N., Castagna, M., Marciani, P., & Perego, C. (2023) · Biomolecules · doi:10.3390/biom13020224 · Cited by 24
“Despite reports indicating insulin expression in tissues, such as the brain or liver [1,2], the pancreatic β-cells remain the major source of insulin biosynthesis and secretion; therefore, their dysfunction and/or death result in decompensated glucose homeostasis and diabetes development [3,4].”
BackgroundOfori, J. K., Karagiannopoulos, A., Barghouth, M., Nagao, M., Andersson, M. E., Salunkhe, V. A., Zhang, E., Wendt, A., & Eliasson, L. (2022) · Acta Physiologica · doi:10.1111/apha.13857 · Cited by 20
Self-citationPreliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder
Zhang, X., Norton, J. L., Carrière, I., Ritchie, K. A., Chaudieu, I., Ryan, J. L., & Ancelin, M. (2017) · Scientific Reports · doi:10.1038/srep42676 · Cited by 25
Holz, G. G., Leech, C. A., & Chepurny, O. G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.023 · Cited by 20
Zhou, X., Zhu, J., Bao, Z., Shang, Z.-H., Wang, T., Song, J., Sun, J., Li, W., Adelusi, T. I., Wang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep37293 · Cited by 21
“However, it has been reported that neither patients with cardiac arrhythmia caused by KCNQ1 mutations nor Kcnq1 -null mice demonstrate hyperglycemia or glucose intolerance 27,28 , whereas KCNQ1 knockdown in human islets does not alter insulin secretion 29 .”
Teplizumab’s immunomodulatory effects on pancreatic β-cell function in type 1 diabetes mellitus
Kokori, E., Olatunji, G. D., Ogieuhi, I. J., Aboje, J. E., Olatunji, D., Aremu, S. A., Igwe, S. C., Moradeyo, A. A., Ajayi, Y. I., & Aderinto, N. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-024-00181-w · Cited by 18
van der Kroef, S., Noordam, R., Deelen, J., Akintola, A. A., Jansen, S. W. M., Postmus, I., Wijsman, C. A., Beekman, M., Mooijaart, S. P., Slagboom, P. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149992 · Cited by 18
Selectively Bred Diabetes Models: GK Rats, NSY Mice, and ON Mice
Nagao, M., Esguerra, J. L. S., Wendt, A., Asai, A., Sugihara, H., Oikawa, S., & Eliasson, L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0385-7_3 · Cited by 16
Self-citationRegulation of Pancreatic β-Cell Mass by Gene-Environment Interaction
Asahara, S., Inoue, H., & Kido, Y. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0045 · Cited by 19
Gjesing, A. P., Hornbak, M., Allin, K. H., Ekstrøm, C. T., Urhammer, S. A., Eiberg, H., Pedersen, O. B., & Hansen, T. F. (2014) · Diabetologia · doi:10.1007/s00125-014-3207-y · Cited by 19
Identification of key gene pathways and coexpression networks of islets in human type 2 diabetes
Li, L., Pan, Z., Yang, S., Shan, W., & Yang, Y. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s178894 · Cited by 17
“7,8 However, because of the inaccessibility of enough human pancreatic islets, the causes and underlying mechanisms for impaired islet function of human T2D are still not fully elucidated.”
Fostering improved human islet research: a European perspective
Marchetti, P., Schulte, A., Marselli, L., Schoniger, E., Bugliani, M., Kramer, W., Overbergh, L., Ullrich, S., Gloyn, A., Ibberson, M., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4911-4 · Cited by 19
Self-citationDyson, N. J., Kattner, N., Al-Selwi, Y., Honkanen‐Scott, M., Shaw, M. F., Brack, C. A., Coulthard, R., Flaxman, C. S., Richardson, S. J., & Shaw, J. (2025) · Diabetologia · doi:10.1007/s00125-025-06547-8 · Cited by 21
Cy, Z., Gong, Y., & Liang, J. (2014) · PubMed · Cited by 18
RetractedHormonal Signaling Actions on Kv7.1 (KCNQ1) Channels
Thompson, E., Eldstrom, J., & Fedida, D. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023645 · Cited by 15
Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells
Nagao, M., Lagerstedt, J. O., & Eliasson, L. (2022) · Diabetology International · doi:10.1007/s13340-022-00580-3 · Cited by 15
Self-citationCa2+ signaling and metabolic stress-induced pancreatic β-cell failure
Magnuson, M. A., & Osipovich, A. B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1412411 · Cited by 19
Loss of β-Cell KATP Reduces Ca2+ Sensitivity of Insulin Secretion and Trpm5 Expression
York, N., Yan, Z., Osipovich, A. B., Tate, A. L., Patel, S., Piston, D. W., Magnuson, M. A., Remedi, M. S., & Nichols, C. G. (2024) · Diabetes · doi:10.2337/db24-0650 · Cited by 14
Human pancreatic islet miRNA-mRNA networks of altered miRNAs due to glycemic status
Karagiannopoulos, A., Esguerra, J. L. S., Pedersen, M. G., Wendt, A., Prasad, R. B., & Eliasson, L. (2022) · iScience · doi:10.1016/j.isci.2022.103995 · Cited by 14
“The islets were processed as previously described (Andersson et al., 2012) and handpicked under stereomicroscope before use.”
MethodSelf-citationGenetics and epigenetics in gestational diabetes contributing to type 2 diabetes
Kong, D., Kowalik, O., Garratt, E. S., Godfrey, K. M., Chan, S., & Teo, A. K. K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.014 · Cited by 16
Hyltén-Cavallius, L., Iepsen, E. W., Christiansen, M., Graff, C., Linneberg, A. R., Pedersen, O. B., Holst, J. J., Hansen, T. F., Torekov, S. S., & Kanters, J. K. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.04.018 · Cited by 14
Lubberding, A. F., Zhang, J., Lundh, M., Nielsen, T. S., Søndergaard, M. S., Villadsen, M., Skovhøj, E. Z., Boer, G. A., Hansen, J. B., Thomsen, M. B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90452-8 · Cited by 16
Zhang, Y.-X., Liu, Y., Dong, J., Wang, Y., Wang, J., Zhuang, G.-Q., Han, S.-J., Guo, Q.-Q., Luo, Y.-X., Zhang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056365 · Cited by 15
“Furthermore, common variants of KCNQ1 have been shown to be associated with reduced insulin granule docking and depolarization-evoked insulin exocytosis [10], and impairment in insulin secretion during glucose loading [11].”
BackgroundTranscriptional Regulation of the Pancreatic Islet: Implications for Islet Function
Stitzel, M. L., Kycia, I., Kursawe, R., & Ucar, D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0635-0 · Cited by 13
“The rs553668 risk allele leads to ADRA2A overexpression in islets and impaired insulin secretion in risk allele carriers [4], [78].”
InfluentialDifferential Gene Expression in GPR40-Overexpressing Pancreatic β-cells Treated with Linoleic Acid
Kim, I. S., Yang, S., Han, J., Jung, S., Park, H.-S., & Myung, C. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.2.141 · Cited by 17
From genotype to human β cell phenotype and beyond
Marchetti, P., Syed, F., Suleiman, M., Bugliani, M., & Marselli, L. (2012) · Islets · doi:10.4161/isl.22282 · Cited by 13
Adefurin, A., Vanderbilt, C. M., Okafor, C., Kawai, V. K., Li, C., Shah, A., Wei, W., Kurnik, D., & Stein, C. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.079 · Cited by 12
Genetic Architecture of Type 2 Diabetes
Prasad, R. B., & Groop, L. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch14 · Cited by 12
Self-citationRNA mutations in the moth pheromone gland
Peng Ru, D. G. (2014) · RNA & DISEASE · doi:10.14800/rd.240 · Cited by 13
“This is particularly important for insulin granule biogenesis and insulin secretion, hormone signalling, trafficking of receptors in plasma membranes and release of neurotransmitters at the synaptic level [21-26] .”
BackgroundQuantification of changes in human islet G protein‐coupled receptor mRNA expression in obesity
Lyu, Z., Zhao, M., Atanes, P., & Persaud, S. J. (2022) · Diabetic Medicine · doi:10.1111/dme.14974 · Cited by 10
Kattner, N., Dyson, N. J., Bury, Y. A., TINIAKOS, D. G., White, K., Davey, T., Eliasson, L., Tindale, L., Wagner, B. E., Honkanen‐Scott, M., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.185 · Cited by 10
Self-citationHu, F., Zhang, Y., Qin, P., Zhao, Y., Liu, D., Zhou, Q., Tian, G., Li, Q., Guo, C., Wu, X., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13212 · Cited by 11
Cook, T. W., Wilstermann, A. M., Mitchell, J. T., Arnold, N. E., Rajasekaran, S., Bupp, C. P., & Prokop, J. W. (2023) · Biomolecules · doi:10.3390/biom13020257 · Cited by 12
“The conservation of this TATA box and rare variants raises questions about whether variants such as these could result in T1D or T2D due to heterozygous decreased/increased expression of INS.”
InfluentialKong, X., Hong, J., Chen, Y., Chen, L., Zhao, Z., Li, Q., Ge, J., Chen, G., Guo, X., Lu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071399 · Cited by 10
Pharmacogenetic Aspects of the Treatment of Type 2 Diabetes with the Incretin Effect Enhancers
Tkáč, I., & Gotthardová, I. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0011 · Cited by 11
Velayutham, K., Ramanathan, B., Murugan, J., Murugan, A., Thavamani, V., & Gomathinayagam, R. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_540_19 · Cited by 11
“Genetic variants from the TCF7L2 gene are strongly associated with T2DM and several studies have demonstrated the influence of rs7903146, rs12255372 with risk of incidence, insulin secretion, β cell efficiency and T2DM obesity.[11,12] In conjunction with several other reports, including ours, the results of the presen…”
ResultHuang, K., Li, T., Liu, X., Chen, J., Chien, W.-K., Shiao, Y., Tsang, H., Lin, T., Liao, C., Huang, S., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25775 · Cited by 11
“Other functional investigations have shown that the KCNQ1 genetic variant is involved in beta-cell exocytosis in T2DM, demonstrating the potential of cellular phenotypic characterization in the elucidation of complex genetic disorder through the impairment of β-cell function (Rosengren et al., 2012).”
BackgroundHornbak, M., Allin, K. H., Jensen, M. L., Lau, C. J., Witte, D. R., Jørgensen, M. E., Sandbæk, A., Lauritzen, T., Andersson, Å., Pedersen, O. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104837 · Cited by 9
Bankura, B., Pattanayak, A. K., Ghosh, S., Guria, S., Sinha, A., & Das, M. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100066 · Cited by 9
Different β‐cell secretory phenotype in non‐obese compared to obese early type 2 diabetes
Gudipaty, L., Rosenfeld, N. K., Fuller, C. S., Cuchel, M., & Rickels, M. R. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3295 · Cited by 12
“Similar to the greater impairment of in vivo insulin secretion observed here for non-obese compared to obese T2D, previous ex vivo assessment of islets isolated from donors with T2D also demonstrated more pronounced impairment of glucose stimulated insulin secretion in islets from non-obese compared with obese donors.…”
ResultKotańska, M., Kulig, K., Marcinkowska, M., Bednarski, M., Malawska, K., & Zaręba, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0779-7 · Cited by 8
“Such analysis would be valuable, since α2adrenoceptor antagonists might favorably modulate the pancreatic function and the abnormal insulin secretion [26].”
BackgroundKogiso, T., Sagawa, T., Kodama, K., Taniai, M., Hashimoto, E., & Tokushige, K. (2020) · Nutrition · doi:10.1016/j.nut.2020.111080 · Cited by 8
Jung, S. Y., Bhatti, P., & Pellegrini, M. A. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01435-7 · Cited by 9
Hsiao, Y., Shen, F., Weng, S., Wang, P., Chen, Y., & Lee, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080689 · Cited by 9
“By impairing β-cell function, KCNQ1 confers a risk for T2DM, and was realized to be strongly linked to a greater likelihood of T2DM in European and East Asian populations [50,51].”
BackgroundAn alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
van de Bunt, M. (2016) · Diabetologia · doi:10.1007/s00125-016-4103-4 · Cited by 7
Pedersen, M. G., Salunkhe, V. A., Svedin, E., Edlund, A., & Eliasson, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103874 · Cited by 7
“diabetes is associated with reduced exocytosis [4].”
Self-citationSzczechla, M., Balewska, A., Naskręt, D., Zozulińska‐Ziółkiewicz, D., & Uruska, A. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45030126 · Cited by 12
Lessons from basic pancreatic beta cell research in type-2 diabetes and vascular complications
Eliasson, L., Esguerra, J. L. S., & Wendt, A. (2017) · Diabetology International · doi:10.1007/s13340-017-0304-4 · Cited by 7
Self-citationNagao, M., Asai, A., Eliasson, L., & Oikawa, S. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0253 · Cited by 7
Self-citationHartwell, H. J., Shang, B., Douillet, C., Bousquet, A. G., Liu, T., Zou, F., Ideraabdullah, F., Stýblo, M., & Fry, R. C. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117242 · Cited by 6
Improving the physiological realism of experimental models
Vinnakota, K. C., Cha, C. Y., Rorsman, P., Balaban, R. S., Gerche, A. L., Wade‐Martins, R., Beard, D. A., & Jeneson, J. A. L. (2016) · Interface Focus · doi:10.1098/rsfs.2015.0076 · Cited by 5
Self-citationJP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential
Marcinkowska, M., Śniecikowska, J., Głuch‐Lutwin, M., Mordyl, B., Bednarski, M., Bucki, A., Sapa, M., Kubacka, M., Siwek, A., Zagórska, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010033 · Cited by 4
“Therefore, lowering the activity of the α 2A -adrenoceptor could help promote insulin release from pancreatic islets and, in turn, decrease high glucose levels [17].”
Li, D., Yin, L., Song, Y.-Q., Shao, N.-N., Zhu, H., He, C.-S., & Sun, J. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i3.552 · Cited by 4
Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
Ding, L., Zhang, Y., Wang, Y., Wang, Y., Tong, Z., Li, P., Chen, C., Wang, B., Yue, X., Li, C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106871 · Cited by 4
“In conclusion, our study provides a working model to explain how Zhx2 modulates b-cell function and b-cell mass, therefore contributing to T2D.”
BackgroundInfluentialCLEC11A improves insulin secretion and promotes cell proliferation in human beta-cells
Shi, R., Cen, J., Westermark, G. T., Zhao, S., Welsh, N., Sun, Z., & Lau, J. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0066 · Cited by 5
“Despite the different causes of type 1 and type 2 diabetes (T2D), beta-cell dysfunction demonstrated by insufficient insulin release in response to hyperglycaemia has become a hallmark of disease progression in these patients (Greenbaum et al. 2009, Rosengren et al. 2012).”
Kotańska, M., Marcinkowska, M., Kuder, K., Walczak, M., Bednarski, M., Siwek, A., & Kołaczkowski, M. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00518-9 · Cited by 4
“Previous studies in mice showed that guanabenz caused an increase in blood glucagon-like peptide 1 (GLP-1) and insulin levels, a decrease in blood glucose level, and an elevation of leptin level along with a reduction in food intake [42].”
BackgroundDramatis Personae in β-Cell Mass Regulation: Enter SerpinB1
Tarasov, A. I., & Rorsman, P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.011 · Cited by 4
Self-citationObstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease
Sharma, A. R., & Vella, A. V. (2016) · Physiology · doi:10.1152/physiol.00009.2016 · Cited by 4
Long QT syndrome presents not only as QT prolongation but also as abnormal T-wave morphology
Horie, M. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.04.032 · Cited by 3
Perturbed Mitochondrial Metabolism in Islets from Donors with Type-2 DiabetesPreprint
Sun, J., Jain, R., Andersson, L. E., Medina, A., Storm, P., Spégel, P., & Mulder, H. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/212548 · Cited by 4
Tamarit‐Rodriguez, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072947 · Cited by 5
“Rosengren A. H. et al. [78] “identified four risk alleles that associate with impaired β -cell exocytosis and enabled us to form a novel genetic risk score for single β -cell dysfunction that involves impaired granule docking and defective Ca 2+ sensitivity of exocytosis”.”
Oxidative and endoplasmic reticulum stress in b-cell dysfunction in diabetes
Hasnain, S. Z., Prins, J. B., & McGuckin, M. A. (2016) · Cited by 3
Interleukin-4 reduces insulin secretion in human islets from healthy but not type-2 diabetic donors
Westholm, E., Edlund, A., Karagiannopoulos, A., Wendt, A., & Eliasson, L. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.092 · Cited by 4
Self-citationEliasson, L. (2014) · Acta Physiologica · doi:10.1111/apha.12235 · Cited by 5
“…current demonstrated to regulate not only neuronal synapses (Li et al. 2013), but also pancreatic islet hormone release (Taneera et al. 2012); and the voltagedependent potassium channel encoded by the KCNQ1 gene demonstrated to regulate exocytosis in hormonesecreting cells (Rosengren et al. 2012).”
BackgroundSelf-citationReis, L. D. D. O., Nassif, P. A. N., Tabushi, F. I., Milléo, F. Q., Fávero, G. M., Ariede, B. L., dos Reis, C. F. D., & Dalabona, B. F. (2016) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-6720201600040009 · Cited by 3
Ferri, G., Tesi, M., Pesce, L., Bugliani, M., Grano, F., Occhipinti, M., Suleiman, M., Luca, C. D., Marselli, L., Marchetti, P., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091403 · Cited by 5
“Please note that this result well agrees with TEM-based estimates obtained on similar models: Rosengren and co-workers, in fact, reported a mean granule diameter from primary human β-cells (285 ± 11 nm [33]), sensibly lower than what was reported for granules in INS-1 E cells (>315 nm [34]).”
ResultPatterns of Insulin Secretion During First-Phase Insulin Secretion in Normal Chinese Adults
Yuan, T., Song, S., Zhao, T., Duo, Y., Wang, S., Gao, J., Liu, S., Dong, Y., Li, R., Fu, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.738427 · Cited by 5
Duvoor, C., Dendi, V. S., Marco, A., Shekhawat, N. S., Chada, A., Ravilla, R., Musham, C. K., Mirza, W., & Chaudhury, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00053 · Cited by 4
“…Thurmond, 2009; Solimena and Speier, 2010; Galvanovskis et al., 2011; MacDonald, 2011; Andersson et al., 2012; Schvartz et al., 2012; Seino, 2012; Rosengren et al., 2012; Wiseman and Thurmond, 2012; Kalwat and Thurmond, 2013; Moghadam and Jackson, 2013; Rorsman and Braun, 2013; Stamper and Wang,…”
BackgroundMazzanti, A., Floriano, M., Kukavica, D., Trancuccio, A., & Priori, S. G. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100525 · Cited by 3
“In LQT1, Rosengren et al. [117] and Yamagata et al. [118] demonstrated that inhibition of KCNQ1 enhances insulin exocytosis.”
Hatamie, A., Gandasi, N. R., Dou, H., Kothegala, L., Eliasson, L., Ewing, A. G., & Rorsman, P. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202509875 · Cited by 3
Self-citationCellular and animal models of type 2 diabetes GWAS gene polymorphisms: what can we learn?
Rutter, G. A. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2013.02.002 · Cited by 2
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_27-1 · Cited by 2
Bioenergetics and Type 2 Diabetes
Doliba, N. M. (2017) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000222 · Cited by 2
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00031-7 · Cited by 3
KCNE Regulation of KCNQ Channels
Abbott, G. W. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-55454-5_25 · Cited by 3
Reduced blood glucose through thyroid hormone degradation product
Eliasson, L. (2016) · Acta Physiologica · doi:10.1111/apha.12847 · Cited by 2
“Indeed, fat droplet accumulation inside human pancreatic beta cells is positively correlated with increased BMI (Rosengren et al. 2012).”
BackgroundSelf-citationHryniewicka, J., Buczyńska, A., Zbucka-Krętowska, M., Kretowski, A. J., & Szelachowska, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021121 · Cited by 3
“HHEX polymorphisms appear to exert a weaker but biologically meaningful effect, acting through altered β -cell regulation and paracrine control of insulin release rather than direct insulin biosynthesis [69,70,72].”
InfluentialXing, J., & Chen, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1805302 · Cited by 2
Metadata
- Authors
- Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., Edlund, A., Pedersen, M. G., Jonsson, A., Ramracheya, R., Tang, Y., Walker, J. N., Barrett, A., Johnson, P. R. V., Lyssenko, V., McCarthy, M. I., Groop, L., Salehi, A., Gloyn, A. L., Renström, E., Rorsman, P., & Eliasson, L.
- Affiliations
- Lund University (SE)
- University of Alberta (CA)
- Churchill Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Eliasson, Lena
- ORCID
- Rosengren, Anders H.
- Braun, Matthias
- Shigeto, Makoto
- Zhang, Enming
- Almgren, Peter
- Ladenvall, Claes
- Edlund, Anna
- Pedersen, Morten Gram
- Jonsson, Anna
- Ramracheya, Reshma
- Tang, Yunzhao
- Johnson, Paul R.V.
- Lyssenko, Valeriya
- McCarthy, Mark I.
- Groop, Leif
- Salehi, Albert
- Gloyn, Anna L.
- Renström, Erik
- Rorsman, Patrik
- Eliasson, Lena
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-06-15
- Volume
- 61
- Issue
- 7
- Pages
- 1726-1733
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3379663
- OpenAlex
- W2168992353
- Cited by
- 237
- References
- 42
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 6 · 2023: 13 · 2022: 14 · 2021: 10 · 2020: 17 · 2019: 12 · 2018: 8 · 2017: 23 · 2016: 27 · 2015: 27 · 2014: 34 · 2013: 22 · 2012: 6
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Wellcome Trust (095101, 095101/Z/10/Z, 095531/Z/11/Z, 090532, 095531)
- Novo Nordisk Fonden (NNF10OC1013350)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- type 2 diabetes, pancreatic beta cells, insulin exocytosis, insulin secretion, genetic risk variants, TCF7L2, ADRA2A, KCNJ11, KCNQ1, GLUT2, granule docking, glucose detection, calcium sensitivity, polygenic risk score, islet ultrastructure
- MeSH terms
- Insulin Secretion, Kcnj11 Channel, Cells, Cultured, Diabetes Mellitus, Type 2, Exocytosis, Humans, Insulin, Transcription Factors, Genetic Variation, Receptors, Adrenergic, alpha-2, Homeodomain Proteins, Genetic Predisposition to Disease, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Glucose Transporter Type 2, KCNQ1 Potassium Channel, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.